Bharat Biotech’s Rotavirus vaccine new formulation gets WHO prequalification

INDIA – Bharat Biotech has announced that the World Health Organization (WHO) has awarded prequalification to its rotavirus vaccine, Rotavac 5D to prevent rotavirus diarrhea. Rotavac 5D, new variant of Rotavac, is a unique rotavirus vaccine formulation that can be administered without a buffer and its low dose volume (0.5 mL) facilitates easy vaccine logistics, cold chain management and low biomedical waste disposal post-vaccination, the company said in a press statement. Rotavac vaccine is used for the prevention of rotavirus infection, which is prevalent in infants and young children. “WHO…

Read More